Publications by authors named "Mathilde Cabart"

Claim this Profile
I
Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study.
Thomas Grellety, Carine Bellera, Coralie Cantarel, Cécile Mertens, Mathilde Cabart

J Geriatr Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response.
Jean-Philippe Guégan, Florent Peyraud, Bérengère Dadone-Montaudie, Diego Teyssonneau, Lola-Jade Palmieri, Mathilde Cabart

Cell Rep Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database.
Mathilde Cabart, Loïc Mourey, David Pasquier, Sophie Schneider, Hervé Léna

J Geriatr Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer.
Alban Bessede, Florent Peyraud, Benjamin Besse, Sophie Cousin, Mathilde Cabart

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer.
Alban Bessede, Florent Peyraud, Sylvestre Le Moulec, Sophie Cousin, Mathilde Cabart

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating video-based consultations in routine clinical practice at a comprehensive cancer center.
Thibaut Mottet, Victor Hémar, Sylvia Enfedaque, Simone Mathoulin-Pélissier, Hélène Charitansky, Mathilde Cabart

Acta Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of FDG- PET CT in the Management of Muscle Invasive Bladder Cancer.
Pauline Bertolaso, Véronique Brouste, Anne-Laure Cazeau, Henri de Clermont-Gallerande, Franck Bladou, Mathilde Cabart

Clin Genitourin Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF).
Laurent Greillier, Manon Gauvrit, Elena Paillaud, Nicolas Girard, Coline Montégut, Mathilde Cabart

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.
Lucile Vanhersecke, Maxime Brunet, Jean-Philippe Guégan, Christophe Rey, Antoine Bougouin, Mathilde Cabart

Nat Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer and PARP inhibitors: progress and challenges.
Diego Teyssonneau, Henri Margot, Mathilde Cabart, Mylène Anonnay, Paul Sargos

J Hematol Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary tumors of the lung: should we consider thermal ablation as a valid therapeutic option?
Jean Palussière, Vittorio Catena, Philippe Lagarde, Sophie Cousin, Mathilde Cabart

Int J Hyperthermia· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Early phase trials at the "Institut de cancérologie de l'Ouest": Clinical outcome and validation of prognostic scores].
Charlotte Greilsamer, Loïc Campion, Mathilde Cabart, Carole Gourmelon, Hélène Senellart

Bull Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib.
Judith Raimbourg, Marie-Pierre Joalland, Mathilde Cabart, Ludmilla de Plater, Fanny Bouquet

Mol Cancer Ther· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study.
Mathilde Cabart, Jean-Sébastien Frénel, Loïc Campion, Jean-François Ramée, Olivier Dupuis

Clin Colorectal Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[KRAS mutation does not influence oxaliplatin or irinotecan efficacy, in association with bevacizumab, in first line treatment of metastatic colorectal cancer].
Mathilde Cabart, Jean-Sébastien Frénel, Loïc Campion, Jean-François Ramée, Olivier Dupuis

Bull Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis